Navigation Links
China's Views on Mental Disorders Improving but Challenges Remain
Date:12/11/2008

Improvements in Awareness and Treatment of Mental Disorders Will Drive China's Psychiatric Drug Market to Reach Nearly $1 Billion by 2012, According to a New Report From Decision Resources

WALTHAM, Mass., Dec. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that China's views on mental disorders are improving but challenges remain. According to the new special Emerging Markets report entitled Issues in Diagnosis and Treatment of Psychiatric Disorders in China, most surveyed Chinese psychiatrists cite lack of awareness about mental disorders, social stigma and potential negative impact on employability as barriers for patients to seek psychiatric treatment, although they foresee improvements in diagnosis and treatment rates during the next five years.

"To improve the treatment of mental health disorders in China, physicians told us that they want drug companies to help increase social awareness of mental disorders," stated Manashi Sherawat, Ph.D., analyst at Decision Resources.

The report also finds that improvements in awareness and treatment of mental disorders will drive the Chinese psychiatric drug market to grow from $250 million in 2007 to nearly $1 billion in 2012. Selective serotonin reuptake inhibitors (SSRIs) could reach $300 - $350 million assuming a 24 percent compound annual growth rate (CAGR). Atypical antipsychotics could reach $650 million assuming a 35 percent CAGR.

"By indication, schizophrenia currently holds the largest share due to the recognition of the need for medical treatment of this condition and the high price of the atypical antipsychotics," added Dr. Sherawat. "By 2012, based on current trends, we anticipate that schizophrenia and bipolar disorder shares will increase slightly, and the share held by major depression and generalized anxiety disorder will decline."

EMERGING MARKETS REPORTS

The Ultimate Analysis of Pharmaceutical Markets in China and India

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Natalia Morales                              Elizabeth Marshall
    Decision Resources                           Decision Resources, Inc.
    781-296-2691                                 781-296-2563
    nmorales@dresources.com                      emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
2. Women who are perceived as confident in job interviews also seen as lacking social skills
3. Latest Breast Imaging Techniques Offer New Views
4. Wrinkle Cream Reviews Site Reveals a Winner for 2008's Best Wrinkle Creams : Wrinkle Cream reviewssite, WrinkleBest.com has released the Editor's Choice for Best Wrinkle Cream of 2008
5. The Public Knows the Candidates Views on Healthcare Reform, But Do the Candidates Know What Healthcare Professionals Think?
6. WebMD Highlights Presidential Candidates Views on Health Care
7. LocumTenens.com Reaps Mixed Reviews on Universal Healthcare
8. SPOKESPERSON AVAILABILTY: Planned Parenthood President Available for Interviews on Proposed HHS Regulations
9. [video] WallSt.nets 3 Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: JSDA, GSPI, JACO, SGTI, HCPC
10. 2008 Mitchell Medical Industry Conference Previews 100 Percent Paperless Auto Medical Claim Solution
11. U.S. Preventive Medicine Views Bernankes Comments as Strong Support for Prevention and Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: